CNS Delivery of Immunotherapy Using MSCs

About the Research Project
Program
Award Type
Standard
Award Amount
$300,000
Active Dates
April 01, 2006 - March 31, 2008
Grant ID
A2006027
Acknowledgement
Summary
The focus of this proposal is on immunotherapy (vaccine) as an experimental approach to treat Alzheimer’s disease. Dr. Cribbs plans to directly delivery specific antibodies to the central nervous system to attack the toxic amyloid peptide that accumulates in the brain. The antibodies will be delivered by the patient’s own stem cells which will be isolated from their bone marrow. These stem cells will be genetically modified to make the antibodies, and then they will be injected into the brain where they will go to the sites of brain inflammation and secrete the therapeutic antibodies.
Related Grants
Alzheimer's Disease Research
Determining the Cellular Impacts of ABCA7 Mutations in Alzheimer’s Disease
Active Dates
July 01, 2025 - June 30, 2027

Principal Investigator
Sarah Heuer, PhD
Current Organization
Brigham and Women's Hospital
Alzheimer's Disease Research
Repairing the Body Clock to Delay Alzheimer's Disease
Active Dates
July 01, 2025 - June 30, 2028

Principal Investigator
Jae-eun Miller, PhD
Current Organization
Columbia University
Alzheimer's Disease Research
Monitoring Neural Activity and Neuroinflammation in Alzheimer’s Disease
Active Dates
July 01, 2025 - June 30, 2028

Principal Investigator
Feng Tian, PhD
Current Organization
Beth Israel Deaconess Medical Center